AJP - GI Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 297: G681-G686, 2009. First published August 13, 2009; doi:10.1152/ajpgi.00238.2009
0193-1857/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/4/G681    most recent
00238.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Fujita, M.
Right arrow Articles by Tamai, I.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujita, M.
Right arrow Articles by Tamai, I.

LIVER AND BILIARY TRACT

Hepatic uptake of {gamma}-butyrobetaine, a precursor of carnitine biosynthesis, in rats

Masaharu Fujita,1 Takeo Nakanishi,1 Yuta Shibue,1 Daisuke Kobayashi,2 Richard H. Moseley,3 Yoshiyuki Shirasaka,1 and Ikumi Tamai1

1Department of Membrane Transport and Biopharmaceutics, Faculty of Pharmacy, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa; 2Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Hokkaido, Japan; and 3Department of Internal Medicine, Ann Arbor Veterans Affairs Healthcare System and University of Michigan School of Medicine, Ann Arbor, Michigan

Submitted June 22, 2009 ; accepted in final form August 6, 2009

{gamma}-Butyrobetaine (GBB) is a precursor in the biosynthesis of carnitine, which plays an important role in the β-oxidation of fatty acids, and is converted to carnitine by {gamma}-butyrobetaine dioxygenase (BBD) predominantly in liver. We investigated the molecular mechanism of hepatic uptake of GBB in rat hepatocytes. Cellular localization of rat Octn2 (rOctn2:Slc22A5) was studied by Western blot analysis. Uptake of deuterated GBB (d3-GBB) was examined in HEK293 cells expressing rOctn2 (HEK293/rOctn2) and freshly isolated rat hepatocytes. d3-GBB was quantified by use of liquid chromatography-tandem mass spectrometry. Western blot analysis demonstrated an expression of OCTN2 protein in hepatic basolateral membrane but not in bile canalicular membrane fraction. Furthermore, we found that d3-GBB was taken up by rOctn2 in an Na+-dependent manner with Km value of 13 µM. The apparent Km value for d3-GBB transport in freshly isolated rat hepatocytes was 9 µM. d3-GBB uptake by the rat hepatocytes was inhibited by {gamma}-aminobutyric acid (GABA) to 30% of the control, whereas it was inhibited by carnitine to 62% of the control, even at 500 µM. Furthermore, d3-GBB uptake by rat hepatocytes was decreased by 45% with rat Gat2 (Slc6A13, a major liver GABA transporter) silenced by the microRNA method. Accordingly, the present study clearly demonstrates that GBB is taken up by hepatocytes for carnitine biosynthesis not only via Octn2 but also via the GABA transporter, possibly Gat2.

Octn2; transporter; hepatocytes; carnitine; {gamma}-butyrobetaine; liver; GABA transporter



Address for reprint requests and other correspondence: I. Tamai, Dept. of Membrane Transport and Biopharmaceutics, Faculty of Pharmacy, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa Univ., Kakuma-machi, Kanazawa, Ishikawa, 920-1192, Japan (e-mail: tamai{at}p.kanazawa-u.ac.jp).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.